Feng Dong

648 total citations
23 papers, 439 citations indexed

About

Feng Dong is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Feng Dong has authored 23 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Feng Dong's work include Thyroid Cancer Diagnosis and Treatment (6 papers), Cancer-related gene regulation (4 papers) and Thyroid Disorders and Treatments (4 papers). Feng Dong is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (6 papers), Cancer-related gene regulation (4 papers) and Thyroid Disorders and Treatments (4 papers). Feng Dong collaborates with scholars based in China, Netherlands and United States. Feng Dong's co-authors include Xudong Wu, Chao Yang, Chunsheng Kang, Xing Liu, Yu Kong, Yan Zhou, Jian Tan, Xing Wang, Lei Sui and Yingjie Yu and has published in prestigious journals such as Nature Communications, Biochemical and Biophysical Research Communications and Cell Reports.

In The Last Decade

Feng Dong

21 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Dong China 10 259 63 57 51 47 23 439
Guanqiao Liu China 10 189 0.7× 47 0.7× 63 1.1× 40 0.8× 25 0.5× 25 459
Sarah E. B. Taylor United States 9 216 0.8× 77 1.2× 58 1.0× 23 0.5× 55 1.2× 9 438
Mohamed H. Khattab United States 9 209 0.8× 32 0.5× 33 0.6× 22 0.4× 42 0.9× 36 426
Hong Seo Lim United States 11 185 0.7× 45 0.7× 46 0.8× 28 0.5× 18 0.4× 20 393
Yongji Tian China 13 160 0.6× 91 1.4× 63 1.1× 50 1.0× 167 3.6× 49 485
Zhaolong Yu United States 7 236 0.9× 46 0.7× 40 0.7× 11 0.2× 24 0.5× 12 505
Hope Mumme United States 8 260 1.0× 62 1.0× 40 0.7× 89 1.7× 47 1.0× 15 522
Arnetha J. Whitmore United States 7 106 0.4× 36 0.6× 35 0.6× 54 1.1× 61 1.3× 11 462
Hualing Sun China 16 241 0.9× 78 1.2× 27 0.5× 14 0.3× 40 0.9× 31 545
Wencong Lv China 7 172 0.7× 71 1.1× 100 1.8× 23 0.5× 13 0.3× 10 322

Countries citing papers authored by Feng Dong

Since Specialization
Citations

This map shows the geographic impact of Feng Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Dong more than expected).

Fields of papers citing papers by Feng Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Dong. The network helps show where Feng Dong may publish in the future.

Co-authorship network of co-authors of Feng Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Dong. A scholar is included among the top collaborators of Feng Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Dong. Feng Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Cao, Lei, Qian Li, Hui Xiong, et al.. (2024). A LATS2 and ALKBH5 positive feedback loop supports their oncogenic roles. Cell Reports. 43(4). 114032–114032. 7 indexed citations
4.
Dong, Feng, Xiaoyu Sun, Qian Li, et al.. (2024). Hypoxia-inducible PRMT2 addiction in glioblastomas. Cellular Signalling. 117. 111094–111094. 5 indexed citations
5.
Cheng, Xuan, Jianxiong Zhao, Feng Dong, & Xuchen Cao. (2021). ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target. Frontiers in Oncology. 11. 759577–759577. 16 indexed citations
6.
Wang, Congcong, Ruiguo Zhang, Renfei Wang, et al.. (2021). Predictive Value of Thyroglobulin Changes for the Curative Effect of Radioiodine Therapy in Patients With Metastatic Differentiated Thyroid Carcinoma. Frontiers in Endocrinology. 12. 667544–667544. 5 indexed citations
7.
Liu, Huimin, Yafei Wang, Jianmin Wu, et al.. (2020). A comparative study of clinical effect of total knee arthroplasty in the treatment of primary osteoarthritis and osteoarthritis of Kashin-Beck disease. International Orthopaedics. 44(9). 1719–1726. 9 indexed citations
8.
Zheng, Huimin, Yingjie Yu, Zhipeng Feng, et al.. (2020). Hierarchical Micro-Nano Topography Promotes Cell Adhesion and Osteogenic Differentiation via Integrin α2-PI3K-AKT Signaling Axis. Frontiers in Bioengineering and Biotechnology. 8. 463–463. 51 indexed citations
9.
Liu, Huimin, et al.. (2020). 5-Aza-2-deoxycytidine inhibits osteolysis induced by titanium particles by regulating RANKL/OPG ratio. Biochemical and Biophysical Research Communications. 529(3). 629–634. 7 indexed citations
10.
Luo, Guangying, Weiwei Xu, Yunping Zhao, et al.. (2020). RNA m6A methylation regulates uveal melanoma cell proliferation, migration, and invasion by targeting c‐Met. Journal of Cellular Physiology. 235(10). 7107–7119. 51 indexed citations
11.
12.
Huang, Kai, Xing Liu, Yansheng Li, et al.. (2019). Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma. Advanced Science. 6(17). 1900782–1900782. 66 indexed citations
13.
Kong, Yu, Feng Dong, Xiujuan Zhao, et al.. (2018). Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. Cell Cycle. 17(10). 1199–1211. 36 indexed citations
14.
Dong, Feng, Qian Li, Chao Yang, et al.. (2018). PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma. Nature Communications. 9(1). 4552–4552. 90 indexed citations
15.
Zhao, Dahang, Ke Chen, Jiang Zhu, et al.. (2015). Postoperative Functional Evaluation of Percutaneous Vertebroplasty Compared With Percutaneous Kyphoplasty for Vertebral Compression Fractures. American Journal of Therapeutics. 23(6). e1381–e1390. 9 indexed citations
16.
Chen, Wen, Zhongna Sang, Long Tan, et al.. (2014). Neonatal thyroid function born to mothers living with long‐term excessive iodine intake from drinking water. Clinical Endocrinology. 83(3). 399–404. 21 indexed citations
17.
Dong, Feng, et al.. (2011). Clinical study on radiofrequency combined with 131I therapy for dedifferentiated thyroid carcinomas. The Chinese-German Journal of Clinical Oncology. 10(5). 274–277. 2 indexed citations
18.
Meng, Zhaowei, et al.. (2010). Visualization of Thyroglossal Duct Cyst in Differentiated Thyroid Cancer Patient. Clinical Nuclear Medicine. 35(7). 499–504. 8 indexed citations
19.
Liu, Hong, Feng Dong, Zhaowei Meng, et al.. (2010). Evaluation of Tourette’s syndrome by 99mTc-TRODAT-1 SPECT/CT imaging. Annals of Nuclear Medicine. 24(7). 515–521. 22 indexed citations
20.
Tan, Jian, et al.. (2009). Thyrotoxicosis Due to Functioning Metastatic Follicular Thyroid Carcinoma After Twelve I-131 Therapies. Clinical Nuclear Medicine. 34(9). 615–619. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026